How Perrigo's Global Vice President of Women's Health, Frederique Welgryn, led the team responsible for bringing the first OTC birth control approved by the FDA to market—and the challenges and setbacks her team overcame along the way. 

Following the world’s first successful xenotransplant of a genetically engineered pig kidney into a living human patient, eGenesis—a biotech company committed to transforming the treatment of organ failure—is closer than ever to accomplishing its ultimate mission: solving the global organ transplant crisis.

To get a sense of what it took to achieve this historic breakthrough, IQ spoke with eGenesis CEO, Dr. Mike Curtis, and Chief People Officer, Elizabeth Roberts, about the incredible milestone and what's next on the company's horizon. 

Artificial intelligence has the potential to transform numerous industries, yet experts believe it could also elevate the best of what it means to be human. This leaves many pundits wondering: will we seize the opportunity?

Joining the discussion are special guests John Kalil and Steve Steinberg, partners at Elixirr, a global consulting firm specializing in AI, data, innovation, and end-to-end digital solutions—and parent company of Insigniam. 

With 25 years of strategy, technology, operations, and business transformation experience, Mr. Kalil often advises Elixirr clients just beginning their AI-journey. 

In addition to being a fellow Elixirr partner, Mr.  Steinberg is also CEO of Responsum, an artificial intelligence company that uses generative AI, large language models (LLMs), and other cutting-edge technology to drive business performance.

As part of Elixirr, both Mr. Kalil and Mr. Steienberg support clients seeking strategic AI guidance and bespoke generative AI solutions to drive massive growth and transformation.

 In our second installment on how Environmental, Social, and Governance (ESG) programs can create a competitive advantage for enterprises worldwide,  Insigniam consultant Tracy Holloman welcomes Dr. Chuck Wallington, Executive Vice President and Chief Marketing & Communications Officer at Cone Health—a not-for-profit network of healthcare providers serving people in North Carolina—who shares his personal experience and perspective on the social aspect of ESG, and what other executives should know when investing in their own ESG programs. 

In today’s highly interconnected economy, many businesses find themselves competing in a global marketplace. This creates a lot of pressure to continually innovate – and not just by developing new products and services. To stay competitive, businesses must continually find ways to improve their structure, processes and culture. To achieve this, innovation must be part of the overall company strategy. 

On Quantum Business Insights with Olivia Parr-Rud, Insigniam partner John Kleinman and consultant Robert Johnson share how their methods have enabled large, complex organizations to generate breakthroughs in their management results—whether that be in topline growth, strategy implementation, better profitability, or culture change. We’ll learn how to create an innovation strategy that enables enterprises to innovate through identifying new strategic frontiers, generating creativity, and executing growth opportunities on those frontiers. Together, we’ll discover how to generate unparalleled dynamic growth by combining breakthrough performance and innovation.

Having led large-scale transformations in nearly every corner of the world, CEO and board chair John Davison says adaptability, resilience, and cultural intelligence can equip corporate directors to elevate the enterprises they support.

For the executive team at Medtronic—pioneers of AI-enabled medical devices—innovation is more than a buzzword, especially when actual lives are on the line. In this group interview, we'll hear from Giovanni Di Napoli, President, Endoscopy; Dr. Austin Lee Chiang, Chief Medical Officer, Endoscopy; and Ha Hong, Chief Artificial Intelligence Officer, Endoscopy, to better understand how the company's game-changing devices are transforming the ability for practitioners and clinicians to care for patients in ways never before possible. 

Axios' China reporter and author of Beijing Rules, Bethany Allen-Ebrahimian,on how China is leveraging capitalism to undermine Westerndemocracies—and potentially your organization.

How Dr. Nejib Ben-Khedher—head of Emirates Skyward—elevates over 30 million customer experiences worldwide, propelling the global carrier to reach stratospheric new heights.

Bonduelle Fresh Americas' senior vice president and executive leadership team member, Gretchen Grani, shares her insights into how Environmental, Social, and Governance (ESG) programs have created a competitive advantage within the U.S. division of the French multinational food company—and what other executives should know when investing in their own ESG programs. 

In this special episode, we'll hear from the executive team at Butler/Till—including board chair Kathleen Brookbanks; CEO Kimberly Jones; COO Mike Della Porta; CMO Amanda DeVito; and CFO Scott Chapman—about how the company's radically successful, employee-owned, women-governed, B Corp agency model outperforms the status quo.

For Michelin North America CEO and President Alexis Garcin, innovating at full throttle while ensuring the 135-year-old mobility company never relegates employees to the backseat is essential for achieving his critical results. 

How PepsiCo’s SVP of Foods R&D, Denise Lefebvre, is leading the food and beverage giant towards designing packaging that’s 100% recyclable, compostable, biodegradable, or reusable by 2025—while stoking her passion for the environment along the way. 

Her career spans nearly every facet of corporate leadership. Now, as a respected board director, Irene Chang Britt sheds light on how boards can propel organizations to achieve rapid value—and why trust is a powerful asset in the boardroom.

Leadership in The Fast Lane

How FORVIA Interiors EVP Jean-Paul Michel is accelerating customer satisfaction at one of the world’s largest automotive suppliers. 

Cone Health became a nationwide DE&I leader and transformed their business and community in the process. Now, CEO Mary Jo Cagle and Chief People & Culture Officer Michelle Adamolekun share their script for unlocking powerful diversity and inclusion.  

For many complex organizations, innovation management processes can help drive value creation. At multinational pharmaceutical and biotechnology company GSK, Julia Pence—head of portfolio and value enablement—is leading just such an endeavor. In this episode, Ms. Pence offers great insight into how and why such a process can create transformational value for an organization—as well as the risk that can arise when no formalized process exists. Her perspective is highly relevant for fellow executives seeking to design and implement an innovation process that creates real value within their respective organizations.  

Kurt Nielsen, former CEO and president of Pharmaceutics International, Inc. (Pii),  on how the paradigm for leadership is changing, and why some CEOs still take a “one-sizefits-all” approach.

Neil Archer, General Manager at Bristol Myers Squibb in Germany,  joins Insigniam podcast co-hosts Jon Ball and Marie-Caroline Chauvet to discuss how to lead an organization through drastic changes, both internally and externally.

Click here to read Mr. Archer's previous interview in the Summer 2022 issue of Insigniam Quarterly.

Syneos Health CEO Michelle Keefe is shattering leadership conventions through radical transparency and crafting unforgettable employee experiences.

How Metlife EVP and Head of Global Technology & Operations, Bill Pappas, harnessed the magic of talent to ensure unrivaled service amid global upheaval. 

Sam Hocking, President, and Co-Founder of the data-driven workforce intelligence tool, Vertis, joins Insigniam consultant Tracy D. Holloman to discuss the transformation of work and how enterprises can better balance the concerns of their employees with the commitments of the organization. 

Alexander Alonso, General Manager of BD Benelux, joins Insigniam Consultant Aaya Hafidi to discuss the importance of a North Star for an organization, and keeping an eye on building the future. 

There is no crystal ball for the future, but with an end goal in mind, we can build scenarios to know how to strategically manage any breakdowns. 

Listen more at https://insigniam.com/podcasts/

Insigniam Consultants Greg Trueblood and Josh LeGassick discuss the importance of consistent feedback in organizations, and the undesired results when it is not present.

Listen more at https://insigniam.com/podcasts/

Pfizer Global Influenza Lead, Oualae Alami joins Insigniam consultant Aaya Hafidi to discuss leading diverse & inclusive teams in a VUCA environment. Oualae Alami shares how influential leaders guide teams by leveraging emotional intelligence, self-awareness, and the ability to create a vision and a path for their people.

Listen more at https://insigniam.com/podcasts/